HP
CARM

Hikari Power’s Carisma Therapeutics CARM Stock Holding History

Hikari Power’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,593
Closed -$220K – 89
2019
Q4 		$220K Hold
10,593
– – 0.02% 93
2019
Q3 		$248K Hold
10,593
– – 0.03% 86
2019
Q2 		$318K Sell
10,593
-10
-0.1% -$299 0.03% 83
2019
Q1 		$218K Buy
10,603
+378
+4% +$6.53K 0.02% 112
2018
Q4 		$290K Buy
10,225
+6,945
+212% +$222K 0.03% 86
2018
Q3 		$141K Buy
+3,280
New +$128K 0.01% 126

Other funds holding CARM

TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return